CING Live signals | Maximize Profits with Getagraph.com

SELL 159246 min ago

@ $1.240

Issued: 13 Feb 2024 @ 09:47

Return: -43.47%

Previous signal: Feb 9 - 10:37

Previous signal: Buy

Return: 7.63 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder...

Stats
Today's Volume	62 001.00
Average Volume	237 088
Market Cap	4.37M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $-2.20 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400
ATR14	$0.0130 (1.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Werth Peter J.	Buy	694 096	Common Stock
2024-04-11	Werth Peter J.	Buy	341 912	Common Stock
2024-04-11	Werth Peter J.	Sell	694 096	Pre-Funded Warrant (right to buy)
2024-04-11	Werth Peter J.	Sell	341 912	Pre-Funded Warrant (right to buy)
2024-03-29	Silva Raul R.	Buy	1 000	Stock Option (right to Buy)

INSIDER POWER
76.95
Last 96 transactions
Buy: 11 671 641 \| Sell: 1 062 040

Volume Correlation

Long: -0.04 (neutral)

Short: 0.95 (very strong)

Signal:(45.648) Expect same movement, but be aware

Cingulate Inc. Correlation

10 Most Positive Correlations
OCEA	0.982
RVYL	0.976
RDHL	0.975
CNSP	0.972
IRBT	0.966
DYFI	0.964
ATLCL	0.962
PMNT	0.962
VRM	0.961
PLL	0.958

10 Most Negative Correlations
OZEM	-1
CCSB	-0.955
DTI	-0.939
CNRLX	-0.936
ISRL	-0.93
EVERX	-0.926
ADTH	-0.921
IROH	-0.92
BAYA	-0.919
GECCI	-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cingulate Inc. Correlation - Currency/Commodity

-0.03
( neutral )

-0.29
( neutral )

0.00
( neutral )

-0.04
( neutral )

Cingulate Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-582 918 (0.00 %)
EPS:	$-26.01

FY	2023
Revenue:	$0
Gross Profit:	$-582 918 (0.00 %)
EPS:	$-26.01

FY	2022
Revenue:	$0
Gross Profit:	$-621 993 (0.00 %)
EPS:	$-31.57

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.831

Financial Reports:

No articles found.

Cingulate Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cingulate Inc.

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.